Health Care
Commentary
Frivolous Patent Litigation Threatens The Technology Revolution
Patent trolls have been a plague on innovators for too long. Patent trolls are entities that obtain patents (sometimes obscure patents) for the sole purpose of threatening or filing lawsuits in court and then using the prospect of costly litigation to extort unwarranted payouts from an innovative company. The risks ...
Commentary
Biden’s health care agenda entrenches a status quo that isn’t working
Health care reform is back on the agenda in Washington. At the end of January, President Biden signed two executive orders that aim to make it easier for people to sign up for coverage. On Saturday, the House passed a $1.9 trillion covid-19 relief package that includes billions in new health insurance subsidies. The ...
Blog
House Covid Bill More About Politics Than Immediate Covid Relief
Late Friday, the House took its first vote to pass President Biden’s $1.9 trillion stimulus package, the first step toward their goal of enacting the plan into law before a March 14 deadline when some unemployment benefits will expire. Much of last week’s media coverage of the plan centered around ...
Commentary
New York’s Single-Payer Healthcare Bill Remains A Disastrous Idea
New York Democrats hope that 2021 is the year socialized medicine finally arrives in the Empire State. Senator Gustavo Rivera, the chairman of the state Senate Health Committee, is reportedly planning to introduce the New York Health Act, which would ban private insurance and force all New Yorkers onto a ...
Commentary
President Biden’s Bipartisan Opportunity to Reduce Patients’ Drug Costs
BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures to patients. Consider that ...
Coronavirus
Dr. Henry Miller Featured in Kaiser Health News on AstraZeneca Vaccine
Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America By Sarah Jane Tribble The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting ...
Commentary
Don’t Overreact to Rising Health Spending
U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more ...
Health Care
Orange County Register Ed Board Quotes PRI’s Sally C. Pipes
Not that any of us needed additional reminders, but Californians in the past year have seen the stark limits of government power as state bureaucracies mishandle their most fundamental responsibilities. We’re all still reeling from the Newsom administration’s contradictory responses to COVID-19. Meanwhile, the state Employment Development Department struggles to ...
Commentary
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
There’s a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in the U.K. have been ...
Commentary
The 340B Prescription-Drug Swindle Has Gone on Long Enough
In a hearing on Tuesday, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services. Becerra dismissed the need to reform the federal “340B” program, even though it has morphed from a good-faith effort to help low-income Americans access medicines ...
Frivolous Patent Litigation Threatens The Technology Revolution
Patent trolls have been a plague on innovators for too long. Patent trolls are entities that obtain patents (sometimes obscure patents) for the sole purpose of threatening or filing lawsuits in court and then using the prospect of costly litigation to extort unwarranted payouts from an innovative company. The risks ...
Biden’s health care agenda entrenches a status quo that isn’t working
Health care reform is back on the agenda in Washington. At the end of January, President Biden signed two executive orders that aim to make it easier for people to sign up for coverage. On Saturday, the House passed a $1.9 trillion covid-19 relief package that includes billions in new health insurance subsidies. The ...
House Covid Bill More About Politics Than Immediate Covid Relief
Late Friday, the House took its first vote to pass President Biden’s $1.9 trillion stimulus package, the first step toward their goal of enacting the plan into law before a March 14 deadline when some unemployment benefits will expire. Much of last week’s media coverage of the plan centered around ...
New York’s Single-Payer Healthcare Bill Remains A Disastrous Idea
New York Democrats hope that 2021 is the year socialized medicine finally arrives in the Empire State. Senator Gustavo Rivera, the chairman of the state Senate Health Committee, is reportedly planning to introduce the New York Health Act, which would ban private insurance and force all New Yorkers onto a ...
President Biden’s Bipartisan Opportunity to Reduce Patients’ Drug Costs
BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures to patients. Consider that ...
Dr. Henry Miller Featured in Kaiser Health News on AstraZeneca Vaccine
Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America By Sarah Jane Tribble The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting ...
Don’t Overreact to Rising Health Spending
U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more ...
Orange County Register Ed Board Quotes PRI’s Sally C. Pipes
Not that any of us needed additional reminders, but Californians in the past year have seen the stark limits of government power as state bureaucracies mishandle their most fundamental responsibilities. We’re all still reeling from the Newsom administration’s contradictory responses to COVID-19. Meanwhile, the state Employment Development Department struggles to ...
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
There’s a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in the U.K. have been ...
The 340B Prescription-Drug Swindle Has Gone on Long Enough
In a hearing on Tuesday, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services. Becerra dismissed the need to reform the federal “340B” program, even though it has morphed from a good-faith effort to help low-income Americans access medicines ...
